Author:
Nakajima Hideki,Miyake Ryota,Hongo Taku,Takasaki Morio,Fujimoto Yasuhiro,Io Katsuhiro
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Surgery
Reference20 articles.
1. Alshiekh-Nasany R, Zidan A, Martinez C (2016) Extensive intracranial arterial stenosis in conjunction with the use of tyrosine kinase inhibitor nilotinib. Clin Case Rep 4:1184–1186
2. Chen CJ, Sorace BJ, Shakeri A, Park MS, Southerland AM, Worrall BB, Kalani MYS (2018) Tyrosine kinase inhibitor induced rapidly progressive vasculopathy after intracranial stent placement. J Neuro Interventional Surg 10:e28
3. Coon EA, Zalewski NL, Hoffman EM, Tefferi A, Flemming KD (2013) Nilotinib treatment-associated cerebrovascular disease and stroke. Am J Hematol 88:534–535
4. Fujiwara S, Fukumoto S, Miyazaki Y, Aso K, Ichikawa H, Onoue S, Iwata S, Ohue S (2021) A case of multiple arterial stenoses due to long-term nilotinib exposure. Jpn J Neurosurg 30:804–810
5. Gomez-Galvan JB, Borrego S, Tovar N, Llull L (2017) Nilotinib as a risk factor for ischemic stroke: a series of three cases. Neurol Engl Ed 32:411–413